[HTML][HTML] Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Background Senescent cells, which can release factors that cause inflammation and
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …
[HTML][HTML] Strategies for late phase preclinical and early clinical trials of senolytics
EOW Gerdes, A Misra, JME Netto, T Tchkonia… - Mechanisms of ageing …, 2021 - Elsevier
Cellular senescence and the hallmarks of aging contribute to age-related disease and
dysfunction. The Unitary Theory of Fundamental Aging Mechanisms highlights the …
dysfunction. The Unitary Theory of Fundamental Aging Mechanisms highlights the …
Cellular senescence in idiopathic pulmonary fibrosis
DL Kellogg 3rd, DL Kellogg Jr, N Musi… - Current Molecular …, 2021 - Springer
Cellular senescence (CS) is increasingly implicated in the etiology of age-related diseases.
While CS can facilitate physiological processes such as tissue repair and wound healing …
While CS can facilitate physiological processes such as tissue repair and wound healing …
Senolytic drugs: from discovery to translation
JL Kirkland, T Tchkonia - Journal of internal medicine, 2020 - Wiley Online Library
Senolytics are a class of drugs that selectively clear senescent cells (SC). The first senolytic
drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis …
drugs Dasatinib, Quercetin, Fisetin and Navitoclax were discovered using a hypothesis …
Senolytics improve physical function and increase lifespan in old age
M Xu, T Pirtskhalava, JN Farr, BM Weigand… - Nature medicine, 2018 - nature.com
Physical function declines in old age, portending disability, increased health expenditures,
and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these …
and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these …
Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age
Aging results in an elevated burden of senescent cells, senescence‐associated secretory
phenotype (SASP), and tissue infiltration of immune cells contributing to chronic low‐grade …
phenotype (SASP), and tissue infiltration of immune cells contributing to chronic low‐grade …
First evidence that senolytics are effective at decreasing senescent cells in humans
GM Ellison-Hughes - EBioMedicine, 2020 - thelancet.com
The increasing life expectancy of the world population has become an economic and global
public health problem. Increased life expectancy tracks with a higher incidence of multiple …
public health problem. Increased life expectancy tracks with a higher incidence of multiple …
Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study
JN Justice, AM Nambiar, T Tchkonia, NK LeBrasseur… - …, 2019 - thelancet.com
Background Cellular senescence is a key mechanism that drives age-related diseases, but
has yet to be targeted therapeutically in humans. Idiopathic pulmonary fibrosis (IPF) is a …
has yet to be targeted therapeutically in humans. Idiopathic pulmonary fibrosis (IPF) is a …
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide
gene. Achieving the same using small molecules would have a tremendous impact on …
gene. Achieving the same using small molecules would have a tremendous impact on …
Cellular senescence: the good, the bad and the unknown
W Huang, LTJ Hickson, A Eirin, JL Kirkland… - Nature Reviews …, 2022 - nature.com
Cellular senescence is a ubiquitous process with roles in tissue remodelling, including
wound repair and embryogenesis. However, prolonged senescence can be maladaptive …
wound repair and embryogenesis. However, prolonged senescence can be maladaptive …